HEALTH● LOW2h ago · Oct 2, 2026, 8:20 PM
Eli Lilly's Jaypirca gains additional indication for untreated leukemia, lymphoma
Seeking Alpha Tech · global
Eli Lilly's drug, Jaypirca, has received an expanded indication for the treatment of previously untreated leukemia and lymphoma. This represents an advancement in cancer therapy.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH55m agoThe FDA says cyclospora was found on a Mexican farm linked to a lettuce outbreakClarínHEALTH57m agoFDA extends review for Novo Nordisk's denecimig for hemophilia ASeeking Alpha TechHEALTH1h agoPatient died by suicide after insurance delayed medication: reportThe Independent WorldHEALTH2h agoBiogen phase 2 litifilimab data boosts lupus candidateSeeking Alpha Tech